论文部分内容阅读
本文报道应用消栓灵治疗脑梗塞23例,以蝮蛇抗栓酶作为对照,进行疗效观察,现报告如下:1 临床资料1.1 一般资料选近一年来住院脑梗塞患者46例,均符合第二届全国脑血管病学术会议诊断要点,并经腰穿或头颅 CT 扫描证实。消栓灵组(治疗组)23例,男19例,女4例;年龄52～70岁。蝮蛇抗栓酶组(对照组)23例,男20例,女3例;年龄51～73岁。两组患者,梗塞部位,病灶大小等基本相似,开始治疗时间均在急
This article reports the application of suppository in the treatment of 23 cases of cerebral infarction, viper antithrombin as a control, the efficacy observed, are as follows: 1 Clinical data 1.1 General Information Select nearly a year hospitalized patients with cerebral infarction in 46 cases, are in line with the second The national cerebrovascular disease academic conference diagnostic points, and confirmed by lumbar puncture or cranial CT scan. There were 23 cases in Xiaohuangling group (treatment group), 19 males and 4 females, aged from 52 to 70 years old. Agkistrodon enzyme group (control group) 23 cases, 20 males and 3 females; aged 51 to 73 years. Two groups of patients, infarction, lesion size and other similar basic start treatment time are urgent